Review for "Renal outcomes and all‐cause death associated with <scp>SGLT</scp> ‐2 inhibitor versus other glucose‐lowering drugs ( <scp>CVD‐REAL</scp> 3 Korea)" Erland Erdmanncrossref（2020）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
